Comments on Triaging My Way To Financial Success: Taking Stock in Pfizer (PFE):

Brad's work is by far the most in-dept analysis I ...

2009-03-20T17:43:00.000-04:00

Brad's work is by far the most in-dept analysis I have found from DYI over the blog sphere. The complete view of the business is the most important part for me as a beginner in DYI.

Excellent Job!

Interesting discussion on the 'critical mass' of l...

2009-03-18T01:32:00.000-04:00

Interesting discussion on the 'critical mass' of large blue chip's and how this relates to the world of dividend growth investing. In 'Investment Zoo' Stephen Jarislowsky mentions companies like Pfizer and Philip Morris as companies investors can invest in for the long haul due to their command of their respective markets. As we've seen with Pfizer and to some extent GE (though that's a different bag altogether) these companies can and do reach a point where they are almost too big and growth becomes forced rather than developed organically.

Another great analysis, thanks Brad.

Cheers,
Mark

Brad,

I am not even going to repeat myself ...

2009-03-16T09:36:00.000-04:00

Brad,

I am not even going to repeat myself so I am not going to say that I enjoyed your analysis a lot. It is definitely worth more than S&P or Value Line reports that charge investors much more for much less..

Despite this however, PFE is a "broken" dividend stock for me.. Maybe a decade from now PFE could find a way in my stock portfolio when it changes its business model to "creating" rather than "buying" drugs.

Thanks,

Susan - I'm glad that the analy...

2009-03-09T20:40:00.000-04:00

Thanks,

Susan - I'm glad that the analysis helped and I won't be buying PFE either any time soon. The purpose of the analysis is to provide an unbiased & objective view of a company from a fundamental perspective and evaluate its investment potential rather than a simple, "buy/sell this stock for this reason".

TMW - I don't think PFE is representative of the entire industry, but it does provide a number of important lessons for investors to consider about the industry. We're seeing consolidation currently (today's Merck & Schering announcement), but these should strategically enhance a company rather than form out of perceived necessity. We're seeing the demise of many large companies due in part to their "critical mass" such as GM, GE, PFE, C, BAC. There comes a point when size doesn't scale in the operations you're targeting for growth and you have to re-evaluate your strategy to find the answers to simple problems.

Great anaylsis. The question is whether PFE is sys...

2009-03-09T18:01:00.000-04:00

Great anaylsis. The question is whether PFE is systemic of the entire industry or an exception?

GREAT analysis. While I probably won't be buying ...

2009-03-09T15:15:00.000-04:00

GREAT analysis. While I probably won't be buying PFE, working through your analysis has helped me a lot. Thanks, Brad.